SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-023155
Filing Date
2024-02-14
Accepted
2024-02-14 10:44:05
Documents
16
Period of Report
2024-02-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246030d1_8k.htm   iXBRL 8-K 50701
2 EXHIBIT 3.1 tm246030d1_ex3-1.htm EX-3.1 33194
3 EXHIBIT 3.2 tm246030d1_ex3-2.htm EX-3.2 115606
  Complete submission text file 0001104659-24-023155.txt   415347

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA thrx-20240214.xsd EX-101.SCH 3018
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE thrx-20240214_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thrx-20240214_pre.xml EX-101.PRE 22361
18 EXTRACTED XBRL INSTANCE DOCUMENT tm246030d1_8k_htm.xml XML 3737
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40869 | Film No.: 24633894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)